Literature DB >> 21816224

In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induced Daxx sumoylation.

Jiwon Hwang1, Robert F Kalejta.   

Abstract

Small ubiquitin-like modifiers (SUMOs) are covalently conjugated to target proteins to regulate numerous biological processes, including subcellular localization, protein-protein interactions, and transactivational activities. While the majority of identified SUMO targets are cellular proteins, SUMO modified viral proteins have also been identified. In addition, there are a growing number of examples where viruses alter the sumoylation status of host cell proteins. Work from our laboratory has previously demonstrated that the human cytomegalovirus (HCMV) virion tegument protein pp71 binds to Daxx, a cellular transcriptional co-repressor, and promotes its sumoylation. Here we describe the in vivo techniques used to detect pp71-induced sumoylation of Daxx in a cotransfection system as well as the endogenous SUMO modified form of Daxx in HCMV-infected cells. The approaches we describe can be easily adapted to infections with other viruses and for the detection of sumoylation of other proteins. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21816224      PMCID: PMC3208771          DOI: 10.1016/j.ymeth.2011.07.004

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  32 in total

1.  A mechanism for inhibiting the SUMO pathway.

Authors:  Roberto Boggio; Riccardo Colombo; Ronald T Hay; Giulio F Draetta; Susanna Chiocca
Journal:  Mol Cell       Date:  2004-11-19       Impact factor: 17.970

2.  The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice.

Authors:  Karim Nacerddine; François Lehembre; Mantu Bhaumik; Jérôme Artus; Michel Cohen-Tannoudji; Charles Babinet; Pier Paolo Pandolfi; Anne Dejean
Journal:  Dev Cell       Date:  2005-12       Impact factor: 12.270

3.  Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin.

Authors:  T Okura; L Gong; T Kamitani; T Wada; I Okura; C F Wei; H M Chang; E T Yeh
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

4.  A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2.

Authors:  R Mahajan; C Delphin; T Guan; L Gerace; F Melchior
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

Review 5.  Western blotting analysis.

Authors:  R J Fido; A S Tatham; P R Shewry
Journal:  Methods Mol Biol       Date:  1995

6.  PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.

Authors:  M N Boddy; K Howe; L D Etkin; E Solomon; P S Freemont
Journal:  Oncogene       Date:  1996-09-05       Impact factor: 9.867

7.  Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.

Authors:  Ding-Yen Lin; Yen-Sung Huang; Jen-Chong Jeng; Hong-Yi Kuo; Che-Chang Chang; Ting-Ting Chao; Chun-Chen Ho; Yun-Ching Chen; Tong-Ping Lin; Hsin-I Fang; Chih-Chang Hung; Ching-Shu Suen; Ming-Jing Hwang; Kun-Sang Chang; Gerd G Maul; Hsiu-Ming Shih
Journal:  Mol Cell       Date:  2006-11-03       Impact factor: 17.970

8.  A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex.

Authors:  M J Matunis; E Coutavas; G Blobel
Journal:  J Cell Biol       Date:  1996-12       Impact factor: 10.539

9.  Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML.

Authors:  J H Ahn; E J Brignole; G S Hayward
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

Review 10.  Viruses and sumoylation: recent highlights.

Authors:  Roberto Boggio; Susanna Chiocca
Journal:  Curr Opin Microbiol       Date:  2006-07-03       Impact factor: 7.934

View more
  7 in total

1.  Dynamic ubiquitination drives herpesvirus neuroinvasion.

Authors:  Nicholas J Huffmaster; Patricia J Sollars; Alexsia L Richards; Gary E Pickard; Gregory A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-25       Impact factor: 11.205

Review 2.  Germinal center kinases in immune regulation.

Authors:  Hailei Yin; Zhubing Shi; Shi Jiao; Cuicui Chen; Wenjia Wang; Mark I Greene; Zhaocai Zhou
Journal:  Cell Mol Immunol       Date:  2012-09-10       Impact factor: 11.530

3.  Inhibition of human cytomegalovirus immediate-early gene expression by cyclin A2-dependent kinase activity.

Authors:  Jennifer D Oduro; Ralf Uecker; Christian Hagemeier; Lüder Wiebusch
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

4.  Regulation of the tumor suppressor PTEN by SUMO.

Authors:  J González-Santamaría; M Campagna; A Ortega-Molina; L Marcos-Villar; C F de la Cruz-Herrera; D González; P Gallego; F Lopitz-Otsoa; M Esteban; M S Rodríguez; M Serrano; C Rivas
Journal:  Cell Death Dis       Date:  2012-09-27       Impact factor: 8.469

5.  Distribution and location of Daxx in cervical epithelial cells with high risk human papillomavirus positive.

Authors:  Shuang-yang Tang; Le Li; Yao-lin Li; An-yuan Liu; Min-jun Yu; Yan-ping Wan
Journal:  Diagn Pathol       Date:  2014-01-08       Impact factor: 2.644

6.  Sumoylation of Notch1 represses its target gene expression during cell stress.

Authors:  Christian J M Antila; Vilma Rraklli; Henri A Blomster; Käthe M Dahlström; Tiina A Salminen; Johan Holmberg; Lea Sistonen; Cecilia Sahlgren
Journal:  Cell Death Differ       Date:  2018-01-05       Impact factor: 15.828

Review 7.  Expanding the Known Functional Repertoire of the Human Cytomegalovirus pp71 Protein.

Authors:  Robert F Kalejta; Emily R Albright
Journal:  Front Cell Infect Microbiol       Date:  2020-03-12       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.